Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Tolerance Study of Three Dosing Regimens of Dextromethorphan (DXM) Reportedly Used in Major Depressive Disorder

NCT04226352 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT04226352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04226352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Tolerance Study of Three Dosing Regimens of Dextromethorphan (DXM) Reportedly Used in Major Depressive Disorder
Lead sponsor
Johns Hopkins University
Phase
Phase 1
Overall status
Completed
Start date
March 15, 2020
Completion date
December 7, 2021
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mdd, smoking, smoking cessation, treatment resistant depression